Peri-operative Outcomes and Survival Following Palliative Gastrectomy for Gastric Cancer: a Systematic Review and Meta-analysis
- PMID: 32959118
- PMCID: PMC7900337
- DOI: 10.1007/s12029-020-00519-4
Peri-operative Outcomes and Survival Following Palliative Gastrectomy for Gastric Cancer: a Systematic Review and Meta-analysis
Abstract
Background: Many patients with gastric cancer present with late stage disease. Palliative gastrectomy remains a contentious intervention aiming to debulk tumour and prevent or treat complications such as gastric outlet obstruction, perforation and bleeding.
Methods: We conducted a systematic review of the literature for all papers describing palliative resections for gastric cancer and reporting peri-operative or survival outcomes. Data from peri-operative and survival outcomes were meta-analysed using random effects modelling. Survival data from patients undergoing palliative resections, non-resective surgery and palliative chemotherapy were also combined. This study was registered with the PROSPERO database (CRD42019159136).
Results: One hundred and twenty-eight papers which included 58,675 patients contributed data. At 1 year, there was a significantly improved survival in patients who underwent palliative gastrectomy when compared to non-resectional surgery and no treatment. At 2 years following treatment, palliative gastrectomy was associated with significantly improved survival compared to chemotherapy only; however, there was no significant improvement in survival compared to patients who underwent non-resectional surgery after 1 year. Palliative resections were associated with higher rates of overall complications versus non-resectional surgery (OR 2.14; 95% CI, 1.34, 3.46; p < 0.001). However, palliative resections were associated with similar peri-operative mortality rates to non-resectional surgery.
Conclusion: Palliative gastrectomy is associated with a small improvement in survival at 1 year when compared to non-resectional surgery and chemotherapy. However, at 2 and 3 years following treatment, survival benefits are less clear. Any survival benefits come at the expense of increased major and overall complications.
Keywords: Gastrectomy; Stomach neoplasms; Survival.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Similar articles
-
Palliative Gastrectomy versus Gastrojejunostomy for advanced Gastric cancer with outlet obstruction: a propensity score matching analysis.BMC Cancer. 2021 Feb 23;21(1):188. doi: 10.1186/s12885-021-07904-7. BMC Cancer. 2021. PMID: 33622258 Free PMC article.
-
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).BMC Cancer. 2019 May 6;19(1):420. doi: 10.1186/s12885-019-5640-2. BMC Cancer. 2019. PMID: 31060544 Free PMC article.
-
Management of gastric cancer.Aust Fam Physician. 2006 Apr;35(4):208-11. Aust Fam Physician. 2006. PMID: 16642236 Review.
-
Safety and feasibility of laparoscopic stomach-partitioning gastrojejunostomy combined with neoadjuvant chemotherapy followed by minimally invasive gastrectomy for resectable gastric cancer with gastric outlet obstruction.Surg Endosc. 2025 Feb;39(2):837-849. doi: 10.1007/s00464-024-11427-0. Epub 2024 Dec 2. Surg Endosc. 2025. PMID: 39623174
-
Liver metastases from gastric carcinoma: A Case report and review of the literature.Curr Probl Cancer. 2017 May-Jun;41(3):222-230. doi: 10.1016/j.currproblcancer.2017.03.003. Epub 2017 Mar 24. Curr Probl Cancer. 2017. PMID: 28625333 Review.
Cited by
-
Palliative Gastrectomy Improves the Survival of Patients with Metastatic Early-Onset Gastric Cancer: A Retrospective Cohort Study.Curr Oncol. 2023 Aug 27;30(9):7874-7890. doi: 10.3390/curroncol30090572. Curr Oncol. 2023. PMID: 37754487 Free PMC article.
-
PALLIATIVE GASTRECTOMY VERSUS GASTRIC BYPASS FOR SYMPTOMATIC CLINICAL STAGE IV GASTRIC CANCER: A PROPENSITY SCORE MATCHING ANALYSIS.Arq Bras Cir Dig. 2024 Feb 5;36:e1790. doi: 10.1590/0102-672020230072e1790. eCollection 2024. Arq Bras Cir Dig. 2024. PMID: 38324851 Free PMC article.
-
Are Palliative Interventions Worth the Risk in Advanced Gastric Cancer? A Systematic Review.J Clin Med. 2024 Sep 28;13(19):5809. doi: 10.3390/jcm13195809. J Clin Med. 2024. PMID: 39407868 Free PMC article. Review.
-
Improvement of Oral Intake after Treatment Using Enteral Feeding Tube for Large Advanced Gastric Cancer Invading Proximal Stomach: A Case Series of 20 Patients.Surg Case Rep. 2025;11(1):24-0143. doi: 10.70352/scrj.cr.24-0143. Epub 2025 Feb 7. Surg Case Rep. 2025. PMID: 39991496 Free PMC article.
-
A prognostic nomogram to predict the cancer-specific survival of patients with initially diagnosed metastatic gastric cancer: a validation study in a Chinese cohort.Clin Transl Oncol. 2025 Jan;27(1):135-150. doi: 10.1007/s12094-024-03576-4. Epub 2024 Jun 25. Clin Transl Oncol. 2025. PMID: 38918302 Free PMC article.
References
-
- Oh JK, Weiderpass E. Infection and cancer: global distribution and burden of diseases. Ann Glob Health. 2014;80(5):384–392. - PubMed
-
- Izuishi K, Mori H. Recent strategies for treating stage IV gastric cancer: roles of palliative gastrectomy, chemotherapy, and radiotherapy. J Gastrointestin Liver Dis. 2016;25(1):87–94. - PubMed
-
- Reim D, Loos M, Vogl F, Novotny A, Schuster T, Langer R, Becker K, Höfler H, Siveke J, Bassermann F, Friess H, Schuhmacher C. Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution. J Clin Oncol. 2013;31(2):263–271. - PubMed
-
- Service NCRaA. Stage Breakdown by CCG 2014. London: NCRAS; 2014.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical